Brief: Sernova and JDRF announce funding of joint research collaboration
12/07/2016 11:01
July 12 (Reuters) - Sernova Corp SVA.V
* Sernova and JDRF announce funding of joint research
collaboration to advance human clinical trials for the treatment
of hypoglycemic unawareness patients with severe type 1 diabetes
* Sernova Corp says JDRF will provide Sernova up to $2.45
million usd to support a clinical trial at a major
transplantation center in United States
Source text for Eikon: ID:nCCN7vfvvY
Further company coverage: SVA.V
Recent news on Sernova Biotherapeutics
See all newsBrief: Seraxis And Sernova Announce Appointment Of Former FDA Medical Officer Dr. Patricia Beaston As Chief Medical Officer Of Seraxis And Post Merger Betanova Biotherapeutics
Brief: Sernova Appoints Jonathan Rigby As Interim Chair
Brief: Sernova Biotherapeutics Provides Positive Interim Data From Ongoing Phase 1/2 Clinical Trial Of Cell Pouch Bio-Hybrid Organ In Patients Living With Type 1 Diabetes
Brief: Sernova Biotherapeutics Secures $4 Million Loan To Further Advance Its Clinical Development Plans
Brief: Sernova Biotherapeutics Inc Study Is On Track To Meet Key Clinical Trial Endpoints